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Abstract
Background Eye Movement Perimetry (EMP) uses Saccadic Eye Movement (SEM) responses for visual field evaluation.
Previous studies have demonstrated significant delay in initiation of SEMs among glaucoma patients in comparison with healthy
subjects. The aim of the current study was to develop an EMP-based screening grid to identify glaucomatous visual field defects.
Methods An interactive test consisting of 36 locations and two stimulus contrasts (162 cd/m2 and 190 cd/m2 on a background of
140 cd/m2) was evaluated in 54 healthy subjects and 50 primary glaucoma patients. Each subject was presented a central fixation
target combined with the random projection of Goldmann size III peripheral targets. Instructions were given to look at each
peripheral target on detection and then re-fixate at the central fixation target while the saccades were assessed using an eye tracker.
From each seen peripheral target, the Saccadic Reaction Time (SRT) was calculated for contrast level 162 cd/ m2. These values
were used to plot Receiver Operating Characteristic (ROC) curves for each test locations and the Area Under the Curve (AUC)
values were used to identify the locations with highest susceptibility to glaucomatous damage. Each stimulus location with an
AUC less than 0.75 along with its mirrored test location around the horizontal axis were eliminated from the grid.
Results The mean age was 48.1 ± 16.6 years and 50.0 ± 14.5 years for healthy subjects and glaucoma patients respectively. A
significant increase of SRT values by 76.5% (p < 0.001) was found in glaucoma patients in comparison with the healthy subjects.
From the ROC analysis, ten out of 36 locations meeting the cut-off criteria of AUC were eliminated resulting in a new grid
containing 26 test locations. SRT values were significantly different (p < 0.05) between the healthy subjects and glaucoma
irrespective of the grids used.
Conclusions The present study resulted in a screening grid consisting of 26 locations predominantly testing nasal, superior and
inferior areas of the visual field. An internal validation of the modified grid showed 90.4% of screening accuracy whichmakes it a
potential approach for population based glaucoma screening.
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Introduction
Glaucoma is a progressive optic neuropathy characterized by
typical structural alterations of the optic nerve associated with
a concomitant visual field defect [1, 2]. Based on a recent
estimate, there are 11.2 million people aged 40 years and
above with glaucoma in India [3]. Because of its asymptom-
atic nature, 90% of glaucoma in the community remains un-
detected [1, 3]. The requirement for additional infrastructure
along with financial constraints makes it yet more challenging
for developing countries like India to deal with the large num-
ber of individuals with glaucoma [3, 4]. Rapid screening for
glaucoma in an at-risk population can enable early interven-
tion, thereby reducing visual morbidity and decline in quality
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of life of an individual with manifest disease [1]. Functional
evaluations using perimetry techniques have been considered
one such potential approach in glaucoma screening [5].
Standard Automated Perimetry (SAP) is the most accept-
ed diagnostic procedure to quantify glaucomatous visual
field defects [2]. In conventional perimetry tests, subjects
are required to sustain a steady central fixation throughout
the course of testing. This might result in Ganzfeld blank out
or Troxler’s fading effect due to neural adaptation [6–11].
This often leads to complaints such as blurred vision, diplo-
pia, inattention, discomfort, hallucination and fatigue. In ad-
dition, the fixation requirement contradicts the natural urge
of the subject to look at new peripheral stimuli, thus com-
plicating the task. Overall, the approach sets up an unnatural
environment for the measurement of human perceptual per-
formance, which can affect the precise measurement of the
visual field [6, 8].
Eye Movement Perimetry (EMP) addresses some of these
concerns, since it is based on the natural human reflexes. A
subject’s performance is based on Saccadic Eye Movements
(SEMs), which means the test results include the properties of
the oculomotor control system [6, 8]. A key parameter of
detected stimuli is the Saccadic Reaction Time (SRT). Past
studies have demonstrated reliable and comparable results be-
tween SAP and EMP in terms of ability to detect visual field
loss [8]. A major benefit of this approach is the elimination of
the need for testing for false positive responses [12]. Although
a small learning curve exists [13], EMP has potential to be-
come the standard in perimetry for young children and people
who have mental or physical limitations to perform conven-
tional perimetry [14, 15].
We have previously shown delayed SRT values in primary
glaucoma patients compared to healthy subjects across differ-
ent eccentricities throughout the tested field of vision [12].
The protocol included all 54 locations tested on the SITA
standard 24–2 test pattern of the Humphrey Visual Field
Analyzer (HFA). Each point was presented at four different
contrasts, thus 216 stimuli in total were shown to each subject
[12]. The test duration of the fixed protocol was 12 min per
eye, which limited rapid screening for any visual field loss.
Therefore, the current study aimed to develop an EMP based
rapid and novel screening grid to identify glaucomatous visual
field defects in participants with primary glaucoma and age-
matched healthy subjects.
Materials and methods
The full threshold grid (54 locations) used in our previous
study (Fig. 1, top panel) followed a fixed stimulus presenta-
tion pattern in which each peripheral stimulus appeared for a
constant duration of 1.2 s with a 0.2 s time gap between sub-
sequent projections with a total test duration of 12 min [12].
An interactive test version was created wherein each stimulus
projection time varied based on the subject’s response. The
protocol was programmed in such a way that peripheral stim-
ulus disappeared immediately after the obtainment of an eye
movement response from the subject.
The EMP test initially consisted of 4 contrasts varying from
subthreshold stimuli (contrast: 192 cd/m2) to suprathreshold
stimuli (contrast: 276 cd/m2) plotted against a 152 cd/m2 back-
ground.We have previously shown that significant differences
in SRTs between healthy subjects and patients with glaucoma
were obtained at an intensity level of 214 cd/m2. Therefore,
we decided to include only 214 cd/m2 and 276 cd/m2 intensity
levels for screening purpose.
Reduction of test locations
A reduction of the tested locations was obtained in two phases.
The first phase was to eliminate irrelevant locations based on
the literature and on clinical observation followed by the sec-
ond phase that focused on an evaluation study in healthy sub-
jects and glaucoma patients using the reduced grid. Based on
Fig. 1 The top panel illustrates the full test grid consisting of 54 locations
and the bottom panel illustrates the modified test grid consisting of 36
locations
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the evaluation outcomes, another reduction in test locations
was obtained by identifying those locations with highest sus-
ceptibility to glaucomatous damage. The loss of sensitivity
near the foveal region occurs relatively late in the process of
glaucomatous damage, when tested with the SAP 24–2 test
algorithm [16, 17]. We, therefore, decided to put more empha-
sis on locations in the peripheral areas of the visual field. The
first reduction of the full threshold 54 location test grid (Fig. 1,
top panel) was obtained by replacing 16 central stimulus lo-
cations (four most central locations in each of the quadrants)
with four new test locations. The eccentricity of these four
locations was calculated as the mean eccentricity of all 16
locations. In addition, the farthest locations (x = ± 15, y = ±
15) in each quadrant were eliminated along with the two test
locations at the blind spot region (15 degree temporal to fixa-
tion) [18] thereby achieving an overall 66.7% reduction of
tested locations (from 54 locations tested four times to 36
locations tested twice), as illustrated in Fig. 1, bottom panel.
Evaluation of the 36 grid point
Participants
Healthy subjects and patients diagnosed with primary glauco-
ma aged between 20 to 70 years were recruited at the outpatient
department and the glaucoma clinic of Sankara Nethralaya (a
tertiary eye care center located in Chennai, India). Healthy
subjects were defined as those with an Intra Ocular Pressure
(IOP) less than 21 mmHg and a healthy anterior and posterior
segment. A dilated posterior segment evaluation was carried
out, including assessment of the optic disc by a glaucoma spe-
cialist along with visual field evaluation by means of the 24–2
Swedish Interactive Thresholding Algorithm (SITA) standard
protocol in the Humphrey Field Analyzer (HFA) to rule out any
clinically evident structural or functional signs of glaucoma.
Exclusion criteria were a Best Corrected Visual Acuity less
than 20/40 for distance and N6 for near, spherical ametropia
greater than ±5.00 D and cylindrical ametropia of more than
−2.00 D, cataract with a grade more than N2, C1, P1 based on
the Lens Opacification Classification System (LOCS) II [19]
and any presence of strabismus, nystagmus or retinal diseases
[12]. Glaucoma subjects were defined on the basis of the
International Society of Geographical and Epidemiologic
Ophthalmology (ISGEO) classification [2]. Patients with pri-
mary open angle or angle closure glaucoma who had
glaucomatous optic disc changes and corresponding reliable
and repeatable visual field defects on HFA were included.
Reliability criteria were as recommended by the instrument’s
algorithm (fixation losses <20%, false positive and false nega-
tive errors <33%). Subjects with glaucoma were classified into
mild, moderate and severe glaucoma based on their visual field
defects by using the Hodapp, Parrish and Anderson’s classifi-
cation. [16].
All the study participants underwent a comprehensive oph-
thalmic evaluation that included visual field examination by
means of two perimetry techniques. First assessment of each
individual’s monocular visual field was done using HFA
(model 750; Carl Zeiss Meditec, Dublin) with SITA
Standard 24–2 white-on-white protocol followed by our cus-
tomized and interactive EMP test [Tobii 120, Tobii, Sweden].
Written informed consent was obtained from all the subjects
before enrolment. The study adhered to the tenets of declara-
tion of Helsinki and the experimental measures were reviewed
and accepted by the Institutional Review Board and Ethics
Committee of Vision Research Foundation, Chennai.
Measurement setup and procedures
The EMP setup consisted of a Tobii 120 infrared eye tracking
device integrated in a 17 in. Thin Film Transistor (TFT) mon-
itor with a refresh rate of 60 Hz as illustrated in Fig. 2. Each
subject was seated in front of the monitor at a fixed working
distance of 60 cm. A chin rest was provided to minimize any
head movements during the test. A constant testing environ-
ment was maintained for all the subjects with dim room illu-
mination and a minimal level of distractions. The right eye
was tested first, followed by the left. The non-tested eye was
covered with a black polymethyl methacrylate (PMMA)
occluder that allowed the infrared eye tracking of the non-
tested eye. Customized testing protocol developed for the cur-
rent study integrated three procedures: a tracking status esti-
mation, a calibration procedure and an interactive EMP test.
Each measurement procedure started with a tracking status
estimation that was necessary to ensure appropriate eye align-
ment and proper gaze tracking. A subject was instructed to
look at all the four corners of the screen to ensure negligible
eye tracking data loss at each corner. Minor alignment adjust-
ments were done when eye tracking was not optimal. Next, a
nine point calibration procedure was done by showing a red
Fig. 2 The Eye Movement Perimetry (EMP) test set up consisting of eye
tracking device and Thin Film Transistor (TFT) monitor
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circular target to align the subject’s gaze with the presented
calibration dots. The calibration procedure was repeated either
for preferred locations or for all the nine locations, if poor
calibration resulting from various factors such as inaccurate
focusing of subjects on the calibration dot, blink artifacts or
any hardware/tracking issues, etc. was noted.
After the calibration process, an interactive EMP test was
started. A Software Development Kit (SDK) was used to as-
sess real time gaze positions at a 60 Hz sample rate. The test
started with plotting a Goldmann size IV central fixation target
(green color) on the eye tracker’s monitor with background
illumination of 152 cd/m2.Meanwhile, real-time gaze tracking
was used to monitor correct central target fixation. A periph-
eral stimulus was projected after a consistent central target
fixation for at least 0.5 s. Goldmann size III peripheral stimuli
of intensity 214 cd/m2 and 276 cd/m2 appeared sequentially
by using an overlap paradigm, which meant that the central
fixation target was kept visible to the subject. A peripheral
stimulus was plotted for a maximum duration of 1.2 s. Yet,
this stimulus was removed when it was fixated within 1.2 s.
All subjects were encouraged to look at detected peripheral
targets followed by refixating at the central fixation stimulus.
To test the visual field up to visual angles of 27 degrees hor-
izontally and 21 degrees vertically, the central fixation target
was repositioned during the test to four eccentric locations.
During the presentation of peripheral stimuli, gaze data was
collected and stored for analysis.
Data analysis and statistics
A custom-written Matlab program was used to analyze and
calculate the properties of SEMs. Figure 3 illustrates the tra-
jectory and time course of a saccade aimed at a peripheral
stimulus projected at location x = 3, y = 15. At the moment
of presenting this stimulus, the gazewas on the central fixation
target (x = 0,y = 0). A peripheral stimulus obtained was la-
beled as Bseen^ if the following criteria were satisfied: (1)
fixation of the central target was followed by a peripheral
stimulus fixation; (2) the angular disparity between the direc-
tion of the primary SEM and the peripheral stimulus location
was less than 45 degrees; (3) the amplitude of the primary
SEM covered more than 50% of the total target distance. A
peripheral stimulus was classified as Bunseen^ when: (1) fix-
ation remained on the central fixation target; (2) the angular
disparity between the direction of the primary SEM and the
peripheral stimulus location was larger than 45 degrees (indi-
cating search behavior). A peripheral stimulus was classified
as Binvalid^ when gaze data was poor due to blinking or pupil
tracking failure. For the events labeled as Bseen^, SRT was
defined as the time between the onset of the target stimulus
and the initiation of the SEM (Fig. 3). This was determined
based on a velocity criterion by calculating the time at which
the eye velocity cross 50 degrees per second [13, 20].
Statistical analyses were performed by using SPSS
(Statistical Package for Social Sciences, version 15,
Chicago, IL, USA). The right eye was considered for analysis.
Tests for normality were carried out for all the continuous
variables and appropriate parametric/non parametric tests
were utilized. Type 1 error was kept at 5% level and all the
tests usedwere two-tailed. Logarithmic transformation of SRT
values in milliseconds was done to reduce the skewness of the
data, thereby achieving a normal data distribution. An inde-
pendent T-test was used to compare SRTs between healthy
subjects and glaucoma patients. The pattern of eye movement
responses was compared between healthy subjects and glau-
coma patients by calculating the percentage of reliably seen,
unseen and invalid subject responses. The stimulus locations
were divided into central and peripheral zones comprising of
four locations and 32 locations respectively. All the 36 tested
locations were represented by their Bx^ and By^ coordinates
(Supplementary figure 1). Of each location, the obtained SRTs
by projecting 214 cd/m2 stimuli were used to construct
Receiver Operating Characteristic (ROC) curves. The Area
Under the Curve (AUC) obtained for 32 test locations in the
Fig. 3 Illustration of the Matlab analysis window used for analyzing the
trajectory and time course of a saccade aimed at a peripheral stimulus
projected at location x = 3, y = 15
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peripheral zone were considered as an index of accuracy in
classifying diseased and non-diseased individuals. The AUC
values obtained for each location were inspected for determin-
ing the minimum AUC cut-off value below which the points
were eliminated along with their mirrored test locations
around the horizontal axis for the maintenance of horizontal
symmetry.
After designing the reduced grid, SRT values were obtain-
ed from both 36 location grid and the modified 26 location
grid. Differences in mean SRT values between healthy sub-
jects and glaucoma patients were analyzed using an indepen-
dent t-test. One-way analysis of variance (ANOVA) was done
to compare the mean SRTs across the four diagnostic catego-
ries (healthy, mild, moderate and severe) using the SRT values
obtained from both grids.
Some healthy subjects had increased SRT values and some
glaucoma patients had SRT values that fell within the normal
range. A fivefold cross validation technique was adapted to
estimate the classification accuracy as a means of internal
validation of the modified grid. The analysis began with gen-
erating five (k = 5) equal sized random subsets from the orig-
inal data set. Of the five samples, a single subsample was
retained as the validation data for the testing model, and the
remaining four subsamples (k-1) were used as training data.
The cross validation process was then repeated five times,
with each of the five subsamples used exactly once as the
validation data thereby calculating five SRT cut-off values
using binary logistics (SPSS). These cut-off values were av-
eraged to compute a single estimation of classification accu-
racy. Finally, to investigate the test duration of the modified
grid, another five healthy subjects and 5 glaucoma patients
underwent the modified EMP screening test.
Results
A total of 104 participants were recruited that included 54 age-
matched healthy subjects and 50 glaucoma patients. The de-
mographic details of the subjects are presented in Table 1.
The glaucoma patients consisted of 24 (48%), 17 (34%)
and 9 (18%) individuals with mild, moderate and severe forms
of the disease, respectively. In Table 2, the test performance is
summarized by analyzing the percentage of seen points, un-
seen points due to visual field defects and invalid points due to
poor gaze tracking.
Supplementary table 1 describes the AUC calculated for
each stimulus locations in the central and peripheral zones.
An illustration of one of the point wise ROC analysis outputs
is presented in Fig. 4. The AUC values calculated for four
central stimulus locations (x = +/−6 and y = +/−6) ranged from
0.71 to 0.81. By inspecting the range of AUC values obtained
for the peripheral zone, a cut-off value of 0.75 was decided.
We found ten peripheral locations with an AUC below this
cut-off and these locations were eliminated from the test grid,
resulting in a 26 location grid as in Fig. 5 (illustrates new
stimulus grid for the left eye with 26 test locations).
Comparison of SRT values obtained from the 36
and 26 location grid
The mean SRT values obtained in the 36 location grid were
427 ± 113 ms and 754 ± 194 ms among healthy subjects and
glaucoma patients, respectively which was statistically signif-
icantly different (p < 0.001; Independent t-test). In the 26 lo-
cation grid, the mean SRT values were 435 ± 116 ms for
healthy subjects and 806 ± 234 ms for glaucoma patients.
Again, this difference was statistically significantly different
(p < 0.001; Independent t-test). SRT values obtained from
both the grids did not show any significant difference.
One-way ANOVA was performed to compare the SRT
values within each diagnostic category obtained from both
the grids. When the 36 location grid was analyzed, a signif-
icant difference in SRT values (p < 0.05) was noted between
each of the diagnostic categories (healthy and mild, moder-
ate and severe glaucoma). The same results were found
when this analysis was carried out with the SRT values
obtained from the 26 location grid (p < 0.05). The Tukey
post-hoc test revealed that increasing disease severity result-
ed in increased SRT values. No significant difference in SRT
values were noted between 36 and 26 location grids.
Figure 6 illustrated the comparison of Saccadic Reaction
Time values obtained from 36 and 26 location grid.
Although significant on a group level, not all glaucoma
patients had a delayed reaction time. Based on a fivefold cross
validation analysis, an overall classification accuracy of
90.4% (10.9) which was considered as an internal validation
of the modified grid.
Finally, the average test duration (per eye) using the 36
location grid was 3.2 ± 0.3 min and 5.3 ± 0.6 min respectively
among healthy subject and glaucoma patients. After the mod-
ification, a small pilot in five healthy subject and five
Table 1 Demographics of the study population
Subject characteristics Healthy subjects
(n = 54)
Patients
(n = 50)
Mean age (SD) in years 48.1 (16.6) 50.0 (14.5)
Gender (in percentage)
Male 31 (57.4%) 38 (76.0%)
Female 23 (42.6%) 12 (24.0%)
Mean Intraocular Pressure
in mm Hg (SD)
14.25 (2.58) 16.15 (3.69)
Mean Cup-to-Disc ratio (SD) 0.39 (0.13) 0.66 (0.17)
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glaucoma patients showed a test duration of 1.2 min ± 0.3 and
2.9 ± 0.6 min, respectively.
Discussion
This study aimed at developing a screening protocol for de-
tecting glaucomatous visual field loss by utilizing an ideal
screening approach, which can be economical, easily admin-
istrable, rapid and reliable. The use of eye tracking technology
offers a non-invasive, low-cost, easily administrable and ob-
jective method for measuring Saccadic Reaction Time (SRT)
that can be used as an index for evaluating the functional
visual aspects [7, 8].
As the intention was to screen for glaucomatous defects,
maximum preference was given to evaluate the peripheral
visual field areas. Therefore, the developed test grid had 26
stimulus locations comprising of four central locations and 22
test locations in the peripheral zones, predominantly testing
nasal, superior and inferior of the visual field. The four central
test locations were placed at slightly eccentric positions, i.e. 8
degrees from the grid center. This might trigger the false cat-
egorization of glaucomatous defects involving only central
visual field as healthy ones, but this proportion might be in-
significant as the early glaucomatous defects tend to affect
Bjerrum area [16, 17]. Two points at the blind spot region
were eliminated due to the high variability of reaction times
reported in the literature [13, 18].
The evaluation of the remaining 36 point grid was carried
out among healthy and glaucoma subjects who were sub-
classified into mild, moderate and severe stages of glaucoma.
The study sample intentionally had a high proportion of mild
Table 2 Pattern of eye movement response for healthy subjects and glaucoma patients in both the stimulus contrast levels
Eye movement response Seen Unseen Invalid
162 cd/m2 190 cd/m2 162 cd/m2 190 cd/m2 162 cd/m2 190 cd/m2
Percentage of response from healthy subjects (n = 54) 90.5 97.7 6.9 1.4 2.6 0.9
Percentage of response from glaucoma patients (n = 50) 57.3 68.6 30.8 22.2 11.9 9.2
Fig. 4 Receiver Operating
Characteristic (ROC) curve ob-
tained for location x=21,y=9 with
an Area Under the Curve (AUC)
of 0.73
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followed by moderate cases with relatively few severe cases.
Inclusion of a large proportion of severe defects of glaucoma
would have resulted in the elimination of valuable test loca-
tions, since in this group the number of unseen points due to
visual field defects is higher. Using this approach we opti-
mized the screening grid for detecting early glaucomatous
defects.
To improve the reliability of assessing saccades, certain
specific features were integrated into the test protocol. A pe-
ripheral stimulus was projected onlywhen central fixationwas
stable. In addition, an overlap paradigm was used, meaning
that the central fixation stimulus was kept visible even during
the projection of subsequent peripheral stimuli, which is a
similar approach used in HFA. When a central stimulus dis-
appears, it might trigger search behavior. Despite this, a
significant difference in eye movement responses was noted
between healthy subjects and glaucoma patients (Table 2). In
spite of instructions to not search for peripheral stimuli, glau-
coma patients still exhibited more searching behavior than
healthy ones, which is in agreement with previous studies
[8]. This behavior might reflect the visual adaptation that glau-
coma patients develop as a compensatory action for their field
defects. Observation of these eyemovement patternsmay give
insight into the real life impact of glaucomatous optic neurop-
athy. The percentage of false negative responses was expected
to be minimal as EMP depended on the natural eye movement
reflex response. The current algorithm could not incorporate
an index for monitoring the possible false negative responses
as we felt it would to lengthen the test duration. The test
administration was noted to be examiner friendly, as the need
Fig. 5 New stimulus grid for the
left eye with 26 test locations
Fig. 6 Comparison of Saccadic
Reaction Time values obtained
from 36 and 26 location grid
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for continuous monitoring of the subject’s response and re-
peated instructions were minimal.
Since perimetry is a psychophysical procedure that shows
intra-test and inter-test fluctuations and variability, the Receiver
Operating characteristic (ROC) curve was considered to be an
efficient approach in identifying the test locations for developing
the screening grid. The Area Under the Curve (AUC) summa-
rizes the entire location of the ROC curve instead of considering
single measures of sensitivity and specificity [21]. Therefore,
AUC values were considered as an index of accuracy. We
interpreted the AUC of a particular stimulus location as the prob-
ability to have high risk of glaucomatous damage. From Fig. 6
and supplementary table 1 it is apparent that this strategy did
result in the elimination of locations, which are suspected to have
poor discriminating value from clinical evidence. Faster reaction
times were noted for stimulus projected at 276 cd/m2 in compar-
ison with 214 cd/m2 and this observation was in accordance with
the previous literature [13]. Mean SRT values obtained from 36
and 26 location grids were compared across four diagnostic cat-
egories, i.e. healthy, mild, moderate and severe glaucoma (Fig.
6). The difference inmean SRT (obtained from two grids) ranged
from 7.5–76.8 ms, which was not statistically significant, i.e. the
mean SRT values did not show a significant change even after
the removal of ten locations.
Even though Pel et al. measured the SRT values using
comparable background and stimulus intensity levels we used
in our setup, our healthy subjects exhibited higher SRT values
[11]. A possible explanation could be the higher mean age of
our study sample. A similar approach was used in the work
published by Thepass et al. on the effect of cataract on EMP.
Here, higher luminance intensity levels were used, up to
~450 cd/m2, which presumably explains the faster SRT values
they reported compared to our results [20].
A five fold cross validation analysis was done on the global
SRT values of all subjects to have a first evaluation of the
classification ability of the 26 location grid. In this method
the original data sample (n = 104) was randomly partitioned
into five subsamples, and one was left out in each iteration.
This method was adapted because repeated random sub-
sampling results in eventually using all subsets as both train-
ing and validation data whereas they are considered exactly
once for validation. In this study, a single mean global SRT
value per subject, as calculated from the 26 locations, was
used for calculating the accuracy which is a rough estimate
of the tested visual field responsiveness. A refinement might
be achieved when a point-wise analysis is done to further
evaluate its screening ability in identifying healthy subjects
and patients with different grades of glaucoma. A clinical
comparison of EMP screening grid should be done preferably
with the current standard method (Frequency Doubling
Perimetry) and the test-retest variability has to be analyzed
[4, 22]. Further testing in patients diagnosed with non-
glaucomatous defects would also be required.
A 90.4% of average classification accuracy was calculated
while using global SRTobtained using 26 test location grid for
categorizing healthy subjects and glaucoma. This suggests
that SRT values can be promising index for detection of
glaucomatous visual field defects. The simplicity of testing
technique and strategy could potentially reduce the need for
close supervision thereby allowing an easier administration of
the test without relying on trained personnel. This can be a
reliable approach for static perimetry specifically in pediatric
and geriatric subjects.
Conclusion
The current study resulted in an interactive EMP test grid with
26 locations which were predominantly placed in the nasal,
superior and inferior areas of the visual field. Reduction of
tested points resulted in reduction of test times with no signif-
icant changes in mean SRT values compared to a larger grid.
Fivefold cross validation technique revealed the ability of the
grid to accurately classify 90.4% of subjects into healthy and
glaucoma on the basis of mean global SRT values.
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